跳至主要内容
临床试验/NL-OMON47250
NL-OMON47250已完成不适用

Multi-center, randomized non-inferiority trial of early treatment versus expectative management of patent ductus arteriosus in preterm infants. - BeNeDuctus Trial

Radboud Universitair Medisch Centrum0 个研究点目标入组 435 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
435

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 11(—)

入选标准

  • - Gestational age < 28 completed weeks
  • - PDA diameter > 1.5 mm and ductal (predominantly) left-to-right shunt
  • - Signed informed consent obtained from parent(s) or representative(s)

排除标准

  • - Contraindication for administration of cyclooxygenase-inhibitors (COXi)
  • - Use of COXi prior to randomization
  • - Persistent pulmonary hypertension (ductal right-to-left shunt *33% of cardiac cycle)
  • - Congenital heart defect, other than PDA and/or PFO
  • - Life-threatening congenital defects
  • - Chromosomal abnormalities and/or congenital anomalies associated with abnormal neurodevelopmental outcome

研究者

相似试验